Roger Emerson, MD
Adult Reconstructive Orthopaedic Surgery · Plano, TXNPI 1215972559
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $656,668 of the $691,451 with a category attached, or 95.0%. Zimmer Biomet accounts for 99.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $243,317 and has fallen 99.8% since, to $517 in 2025. Among adult reconstructive orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $5621.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$690K
- Bone Support Inc.$368
- Shalby Advanced Technologies, Inc.$324
- Merge Healthcare Incorporated$228
- Pacira Pharmaceuticals Incorporated$217
- BD$169
- plus $564 from 13 others
Across 40 payments — averaging $7731.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$309K
What the payments were for
- Royalty or licence$656,66895%
- Consulting fees$27,6754%
- Travel & lodging$1,9170%
- Food & beverage$3,0480%
- Education$2,1420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 78 | $689,580 |
| Bone Support Inc. | 6 | $368 |
| Shalby Advanced Technologies, Inc. | 1 | $324 |
| Merge Healthcare Incorporated | 1 | $228 |
| Pacira Pharmaceuticals Incorporated | 6 | $217 |
| BD | 2 | $169 |
| Ferring Pharmaceuticals Inc. | 6 | $122 |
| Bioventus LLC | 3 | $76 |
| Johnson & Johnson | 4 | $63 |
| Medacta USA, Inc. | 1 | $59 |
| Vertex | 3 | $52 |
| Pacira Therapeutics, Inc. | 3 | $51 |
| Davol Inc. | 2 | $47 |
| Stryker | 2 | $29 |
| Next Science LLC | 1 | $23 |
| Kerecis Limited | 1 | $20 |
| Solventum Corporation | 1 | $19 |
| Salvin Dental Specialties, Inc. | 1 | $3 |
| Endotronix, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Taperloc$659,068
- G7$12,050
- Oxford$9,125
- Echo$7,250
- Continuum Shell$7,250
- Anterior Supine$2,400
- Persona$2,142
- Comprehensive Micro Stem$1,200
- PPK$263
- Software$228
- Comprehensive Shoulder System$198
- CERAMENTBONE VOID FILLER$159
- Surgiphor$150
- Connected Health Product Portfolio$148
- Surgical Product Portfolio$125
- EXPAREL$104
How this compares
$691,451 in reported general payments places this provider in the 95th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.
See all adult reconstructive orthopaedic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 155 | $888 |
| Gabapentin | 49 | $347 |
| Amoxicillin | 198 | $307 |
| Meloxicam | 57 | $239 |
| Tramadol Hcl | 52 | $169 |
| Ondansetron OdtOndansetron | 15 | $119 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $103 |
| Cephalexin | 36 | $86 |
| Clindamycin Hcl | 20 | $49 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Plano
- John BarringtonPlano$2.2M
- Richard ReitmanPlano$227K
- Kwame EnninPlano$132K
- Tyler GoldbergAustin$4.6M
- Antonia ChenDallas$3.8M
- Donald HohmanDallas$537K
- Steven WeedenFort Worth$370K
- Marcus FordFort Worth$296K
- Raul MarquezEdinburg$278K
- Brian FullerCarrollton$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.